Letharia vulpina, a vulpinic acid containing lichen, targets cell membrane and cell division processes in methicillin-resistant Staphylococcus aureus

Pharmaceutical Biology

Volumn 54, Issue 3, 2016, Pages 413-418

  Shrestha, Gajendra ^a   Thompson, Andrew ^a   Robison, Richard ^a   St Clair, Larry L ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Antibiotics; lichens; mode of action; MRSA

Indexed keywords

ANTIINFECTIVE AGENT; FUNGAL EXTRACT; LETHARIA VULPINA EXTRACT; UNCLASSIFIED DRUG; VULPINIC ACID; FURAN DERIVATIVE; PHENYLACETIC ACID DERIVATIVE; PLANT EXTRACT;

ARTICLE; BACTERIAL STRAIN; BACTERIOLYSIS; BACTERIUM COLONY; CELL DIVISION; CELL KILLING; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; LETHARIA VULPINA; LICHEN (ORGANISM); MEMBRANE DAMAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PARMELIACEAE; PROPIDIUM IODIDE ASSAY; THIN LAYER CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; CELL DIVISION; CELL MEMBRANE; FURANS; HUMANS; LICHENS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PARMELIACEAE; PHENYLACETATES; PLANT EXTRACTS;

EID: 84956640797     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1038754     Document Type: Article

References (40)

1. Abo-Khatwa AN, Al-Robai AA, Al-Jawhari DA. (1996). Lichen acids as uncouplers of oxidative phosphorylation of mouse-liver mitochondria. Nat Toxins 4: 96-102
2. Alwash MS, Ibrahim N, Ahmad WY. (2013). Identification and mode of action of antibacterial components from Melastoma malabathricum Linn. leaves. Am J Infect Dis 9: 46-58
3. Andra J, Jakovkin I, Grotzinger J, et al. (2008). Structure and mode of action of the antimicrobial peptide arenicin. Biochem J 410: 113-22
4. Araújo AAS, de Melo MGD, Rabelo TK, et al. (2015). Review of the biological properties and toxicity of usnic acid. Nat Prod Res. [Epub head of print]. doi: 10.1080/14786419.2015.1007455
5. Arndt-Jovin DJ, Jovin TM. (1989). Fluorescence labeling and microscopy of DNA. Method Cell Biol 30: 417-48
6. Boustie J, Tomasi S, Grube M. (2011). Bioactive lichen metabolites: Alpine habitats as an untapped source. Phytochem Rev 10: 287-307
7. Burkholder PR, Evans AW, Mcveigh I, Thornton HK. (1944). Antibiotic activity of lichens. Proc Natl Acad Sci USA 30: 250-5
8. Carson CF, Mee BJ, Riley TV. (2002). Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicro Agents Ch 46: 1914-20
9. Cocchietto M, Skert N, Nimis P, Sava G. (2002). A review on usnic acid, an interesting natural compound. Naturwissenschaften 89: 137-46
10. Collignon PJ. (2002). Antibiotic resistance. Med J Aust 177: 325-9
11. Francolini I, Norris P, Piozzi A, et al. (2004). Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicro Agents Ch 48: 4360-5
12. Galun M. (1988). CRC Handbook of Lichenology (Vol II). Boca Raton (FL): CRC Press, Inc
13. Gilbert P. (1984). The revival of micro-organisms sublethally injured by chemical inhibitors. Soc Appl Bacteriol Symp Ser 12: 175-97
14. Gupta V, Verma S, Gupta S, et al. (2012). Membrane-damaging potential of natural l-(-)-usnic acid in Staphylococcus aureus. Eur J Clin Microbiol 31: 3375-83
15. Hunn ES. (1990). Nch'i-Wana, "The Big River": Mid-Columbia Indians and Their Land. Seattle: University of Washington Press
16. Isnansetyo A, Kamei Y. (2003). MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against methicillin-resistant Staphylococcus aureus. Antimicro Agents Ch 47: 480-8
17. Kokubun T, Shiu WK, Gibbons S. (2007). Inhibitory activities of lichen-derived compounds against methicillin-and multidrug-resistant Staphylococcus aureus. Planta Med 73: 176-9
18. Lauterwein M, Oethinger M, Belsner K, et al. (1995). In vitro activities of the lichen secondary metabolites vulpinic acid,(+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicro Agents Ch 39: 2541-3
19. Lawrey JD. (1983). Vulpinic and pinastric acids as lichen antiherbivore compounds: Contrary evidence. Bryologist 86: 365-9
20. Leeb M. (2004). Antibiotics: A shot in the arm. Nature 431: 892-3
21. Liapikou A, Torres A. (2013). Emerging drugs on methicillin-resistant Staphylococcus aureus. Expert Opin Emerg Dr 18: 291-305
22. Malhotra S, Subban R, Singh A. (2007). Lichens-Role in traditional medicine and drug discovery. Int J Alter Med 2: 1-9
23. Mobashery S, Azucena E. (2002). Bacterial antibiotic resistance. Encycl Life Sci 2: 472-7
24. Molnar K, Farkas E. (2010). Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch(C) 65: 157-73
25. Nobles CL, Green SI, Maresso AW. (2013). A product of heme catabolism modulates bacterial function and survival. PLoS Pathog 9: e1003507
26. Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW. (2001). Antifungal susceptibility testing: Practical aspects and current challenges. Clin Microbiol Rev 14: 643-58
27. Plaza A, Keffer JL, Bifulco G, et al. (2010). Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ. J Am Chem Soc 132: 9069-77
28. Pompilio A, Pomponio S, Di Vincenzo V, et al. (2013). Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. Future Microbiol 8: 281-92
29. Ramos DDBM, Gomes FS, Napoleão TH, et al. (2014). Antimicrobial activity of Cladonia verticillaris lichen preparations on bacteria and fungi of medical importance. Chin J Biol. [Epub ahead of print]. http://dx.doi.org/10.1155/2014/219392
30. Ranković B, Kosanić M, Manojlović N, et al. (2014). Chemical composition of Hypogymnia physodes lichen and biological activities of some its major metabolites. Med Chem Res 23: 408-16
31. Saleem M, Nazir M, Ali MS, et al. (2010). Antimicrobial natural products: An update on future antibiotic drug candidates. Nat Prod Rep 27: 238-54
32. Shrestha G, Raphael J, Leavitt SD, St. Clair LL. (2014). In vitro evaluation of the antibacterial activity of extracts from thirty-four species of North American lichens. Pharm Biol 52: 1262-6
33. Shrestha G, St. Clair LL. (2013a). Antimicrobial activity of extracts from two lichens Ramalina menziesii and Usnea lapponica. Bull California Lichen Soc 20: 5-10
34. Shrestha G, St. Clair LL. (2013b). Lichens: A promising source of antibiotic and anticancer drugs. Phytochem Rev 12: 229-44
35. Sikkema J, De Bont J, Poolman B. (1995). Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 59: 201-22
36. Stapleton PD, Taylor PW. (2002). Methicillin resistance in Staphylococcus aureus: Mechanisms and modulation. Sci Prog 85: 57-72
37. Stojanovic G, Stojanovic I, Smelcerovic A. (2012). Lichen depsidones as potential novel pharmacologically active compounds. Mini-Rev Org Chem 9: 178-84
38. Taylor AR. (2013). Methicillin-resistant Staphylococcus aureus infections. Primary Care 40: 637-54
39. Wang J, Galgoci A, Kodali S, et al. (2003). Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics. J Biol Chem 278: 44424-8
40. Wilson BA, Salyers AA, Whitt DD, Winkler ME. (2011). Bacterial Pathogenesis: A Molecular Approach. Washington (DC): ASM Press